ClinicalTrials.gg
Not yet recruitingNCT07848178Via HabitUpdated Nov 20, 2026

Roybal Via Habit Formation

An interventional study of ViaHabit in Physical Inactivity and Sedentary Lifestlye, sponsored by Louisiana State University and A&M College. Not yet recruiting at 1 site in United States. Open to participants aged 45 Years to 65 Years. Per ClinicalTrials.gov, last updated 2026-11-20.

Sponsored by Louisiana State University and A&M College · Not applicable, Interventional, and Prevention

How we know

Updated Nov 20, 2026Start date movedPrimary completion moved+1 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
10
Allocation
Not applicable
Ages
45 Years to 65 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-21

Among 452 studies in Sedentary Behavior with a site in United States — 61 open to participants now, 89 under way, none of them phase 3. Sedentary Behavior · United States.

Planned enrollment
382nd of 421
10 · median 60
Started
2027
with 1 other
No phase
386 of 452
54 open now
Primary completion
2027-05
later than 48 of 88 live
Registered
450th of 452
by date

Among the 452 studies in Sedentary Behavior with a site in United States, this one is the 382nd largest by planned enrollment of the 421 interventional ones that give a count, is one of 2 that started in 2027, is one of 386 with no phase, reaches primary completion later than 48 of the 88 other live ones, and was the 450th registered.

Sedentary Behavior

1,276 studies on the registry are indexed under Sedentary Behavior; 292 are open to participants now.

Browse Sedentary Behavior studies →

Open to participants now

61 of the 452 studies in Sedentary Behavior with a site in United States are open now. Recruiting first, the newest first:

56 more — sign in →

All 61 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 184 Sedentary Behavior studies recruiting now, 77 (42%) set no upper age limit and 82 (45%) stop at 75 or younger; 30 take children under 18; 97 take healthy volunteers.

This study: 45 Years to 65 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 452 studies in Sedentary Behavior with a site in United States, or all of them as a file.
02

Study summary

This pilot study will develop and evaluate ViaHabit, a personalized walking intervention designed to promote physical activity habit formation among sedentary midlife adults (ages 45-65). During an initial 2-week observation period, participants' daily routines will be characterized using data collected from wearable devices, smartphones, and digital calendars. Personalized models will identify routine transitions, defined as periods between everyday activities, that may serve as receptive opportunities for initiating physical activity. Participants will then complete a 4-week intervention in which they create individualized "if-then" action plans linking routine transitions to a 15-minute brisk walk and receive automated smartwatch prompts at selected cue times. The study will assess the feasibility and acceptability of identifying routine transitions and delivering timely physical activity prompts, while exploring changes in walking behavior, habit strength, and physical activity engagement.

Read the detailed description

This pilot study will develop and evaluate ViaHabit, a personalized, cue-based walking intervention designed to promote physical activity habit formation among sedentary midlife adults. The study is based on the premise that routine transitions, defined as periods when one daily activity has ended and another has not yet begun, may represent receptive opportunities for initiating new health behaviors. The long-term goal is to increase physical activity during midlife, a critical period for reducing risk factors associated with cognitive decline and dementia.

The study will enroll approximately 10 adults aged 45 to 65 years who are physically inactive and experience competing work, caregiving, parenting, or other role demands. Participants must own or be willing to use an iPhone-compatible device and be able to walk without assistance.

The study uses a 12-week, single-arm, within-subject design consisting of two phases. During Phase 1 (2-week observation period), participants will use an Apple Watch, smartphone applications, and digital calendar tools to collect multimodal data on daily behavior, including physical activity, location patterns, calendar events, and contextual information. These data will be used to develop individualized computational models of participants' daily routines and identify recurring routine transitions that may serve as effective cues for physical activity initiation.

Following model development, participants will enter Phase 2 (4-week intervention period). In a virtual coaching session, participants will identify up to two routine transitions that can function as cues for walking and will create personalized "if-then" action plans linking those cues to a 15-minute brisk walk. Automated smartwatch notifications will be delivered when the selected routine transitions occur to increase cue salience and support initiation of physical activity. Walking behavior will be continuously monitored through wearable devices.

The primary objectives are to evaluate the feasibility of identifying individualized routine transitions from passive sensing data and the feasibility and acceptability of delivering a personalized, cue-based walking intervention anchored to those transitions. Secondary and exploratory outcomes include adherence to study procedures, walking behavior, cue-triggered behavioral enactment, habit strength, physical activity levels, and cognitive function. Habit strength will be assessed using measures of behavioral automaticity, while cognitive function will be evaluated through mobile cognitive assessments administered during the intervention period.

The findings will inform the development of scalable, data-driven interventions that leverage naturally occurring daily routines to support physical activity habit formation and healthy aging.

03

Conditions studied

  • Physical Inactivity
  • Sedentary Lifestlye

Keywords

  • Habit Formation
  • Physical Activity
  • Behavioral Intervention
  • Mobile Health (mHealth)
  • Smartwatch
  • Physical Activity Promotion
  • Midlife Adults
  • Behavioral Automaticity
04

Who can participate

Ages eligible
45 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age 45 to 65 years.
  • Reports no leisure-time physical activity during the past month and engages in \<400 MET-minutes/week of physical activity as assessed by the IPAQ-Short Form.
  • Has competing role demands, defined as ≥10 hours/week of paid work, caregiving, parenting, or volunteer activities.
  • Owns an iPhone (iOS smartphone) with reliable internet access and is willing to use study-related mobile applications and wearable devices.
  • Able to walk without assistance.
  • Uses, or is willing to use, a digital calendar application and share de-identified event timing data with the study team.
  • Able to understand study procedures and provide .

Exclusion criteria

Exclusion Criteria:

  • Plans to relocate or engage in extended travel during the next 3 months.
  • Pregnant or planning to become pregnant during the study period.
  • Currently participating in another physical activity or behavioral intervention study.
  • Has a medical condition that may limit safe participation in walking, impair the ability to provide , or interfere with study adherence.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
10 participants (estimated)

Study arms

  • Experimental
    ViaHabit Intervention

    Participants complete a 2-week observation period during which individualized routine models are developed using wearable, smartphone, and calendar data, followed by a 4-week ViaHabit intervention consisting of routine-transition cue selection, if-then action planning, and automated smartwatch prompts to support initiation of 15-minute brisk walks.

    Behavioral: ViaHabit

Interventions

  • BehavioralViaHabit

    ViaHabit is a personalized, cue-based walking intervention designed to promote physical activity habit formation in sedentary midlife adults. Following a 2-week observation period, individualized routine models are developed using data collected from wearable devices, smartphones, and digital calendars. Participants then complete a coaching session to identify up to two routine transitions that can serve as cues for physical activity and develop personalized if-then action plans linking each cue to a 15-minute brisk walk. During the 4-week intervention period, automated smartwatch notifications are delivered at the selected routine-transition cues to increase cue salience and support initiation of walking behavior. The intervention aims to strengthen cue-behavior associations through repeated pairing of routine completion cues with walking, thereby increasing behavioral automaticity and physical activity participation.

06

What researchers measure

Primary outcomes

  1. Feasibliity of the ViaHabit Intervention - Recruitment

    Feasibility will be assessed by participant recruitment rates.

    Time frame: Week 8 (end of intervention)

  2. Feasibliity of the ViaHabit Intervention - Retention

    Feasibility will be assessed by participant retention rates.

    Time frame: Week 8 (end of intervention)

  3. Feasibliity of the ViaHabit Intervention - Data Collection

    Feasibility will be assessed by participant completion of Phase 1 data collection.

    Time frame: Week 8 (end of intervention)

Secondary outcomes

  1. Habit Strength for Walking

    Habit strength will be assessed using the 4-item Self-Reported Behavioral Automaticity Index (SRBAI), adapted to each participant's selected routine-transition cue. Higher scores indicate greater automaticity of walking behavior in response to the cue.

    Time frame: Baseline and weekly during the 4 week intervention period through Week 8

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

2 registry updates since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Jan 2027; primary completion for May 2027, 4 months later.

Of 736 non-industry interventional studies with no phase under Sedentary Behavior, half reached primary completion within 14 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 30. This study's planned 4 months is below that.

Counting every sponsor, half of 744 studies reached it within 14 months; a quarter within 6 and three quarters within 30.

Since we started tracking on Sep 25, 2026, the dates moved once, on Nov 20, 2026: start Oct 2026 → Jan 2027 and primary completion Apr 2027 → May 2027.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Sep 9, 2026
First posted
Sep 29, 2026
StartEst.
Jan 15, 2027was Oct 2026
Primary completionEst.
May 30, 2027was Apr 2027
CompletionEst.
Jun 30, 2027
Last update
Nov 20, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Start date
Oct 1, 2026→Jan 15, 2027
Nov 20, 2026
Primary completion
Apr 30, 2027→May 30, 2027
Nov 20, 2026
Registered
First appeared on the registry
Sep 29, 2026
Show all 2 updates
  1. Nov 20, 2026
    Start date Oct 1, 2026→Jan 15, 2027
    Primary completion Apr 30, 2027→May 30, 2027
    + 1 other change: verification date
  2. Sep 29, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07848178
Lead sponsor
Louisiana State University and A&M College
Responsible party
Shiyu Li, PhD (Assistant Professor, Louisiana State University and A&M College) — Principal investigator
First posted
Sep 29, 2026
Start date
Jan 15, 2027 (estimated)
Primary completion
May 30, 2027 (estimated)
Completion
Jun 30, 2027 (estimated)
Last update
Nov 20, 2026

Study contacts

Shiyu Li, PhD
Contact
sli40@lsu.edu
225-578-0977
Kimberly Allen, MA
Contact
225-578-2363

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion